NO990440L - Preparat som innbefatter mupirocin og klorheksidin - Google Patents

Preparat som innbefatter mupirocin og klorheksidin

Info

Publication number
NO990440L
NO990440L NO990440A NO990440A NO990440L NO 990440 L NO990440 L NO 990440L NO 990440 A NO990440 A NO 990440A NO 990440 A NO990440 A NO 990440A NO 990440 L NO990440 L NO 990440L
Authority
NO
Norway
Prior art keywords
chlorhexidine
preparation
mupirocin
includes mupirocin
treatment
Prior art date
Application number
NO990440A
Other languages
English (en)
Other versions
NO990440D0 (no
Inventor
Monica Lucie Drogemoller
Stanley Leslie Linley
Original Assignee
Smithkline Beecham Farma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Farma filed Critical Smithkline Beecham Farma
Publication of NO990440L publication Critical patent/NO990440L/no
Publication of NO990440D0 publication Critical patent/NO990440D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Farmasøytisk preparat som innbefatter mupirocin og klorheksidin for anvendelse ved behandling av bakterielle infeksjoner, spesielt ved infiserte brannskader.
NO990440A 1996-08-01 1999-01-29 Preparat som innbefatter mupirocin og klorheksidin NO990440D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9616208.6A GB9616208D0 (en) 1996-08-01 1996-08-01 Novel Compounds
PCT/EP1997/004165 WO1998005313A1 (en) 1996-08-01 1997-07-29 Composition comprising mupirocin and chlorhexidine

Publications (2)

Publication Number Publication Date
NO990440L true NO990440L (no) 1999-01-29
NO990440D0 NO990440D0 (no) 1999-01-29

Family

ID=10797878

Family Applications (1)

Application Number Title Priority Date Filing Date
NO990440A NO990440D0 (no) 1996-08-01 1999-01-29 Preparat som innbefatter mupirocin og klorheksidin

Country Status (21)

Country Link
US (1) US6214866B1 (no)
EP (1) EP0921791B1 (no)
JP (1) JP2000517294A (no)
KR (1) KR20000029678A (no)
CN (1) CN1231606A (no)
AR (1) AR008797A1 (no)
AT (1) ATE207350T1 (no)
AU (1) AU708688B2 (no)
BR (1) BR9710899A (no)
CA (1) CA2262430A1 (no)
CZ (1) CZ29199A3 (no)
DE (1) DE69707691T2 (no)
ES (1) ES2163186T3 (no)
GB (1) GB9616208D0 (no)
IL (1) IL128317A (no)
NO (1) NO990440D0 (no)
NZ (1) NZ333896A (no)
PL (1) PL331423A1 (no)
TR (1) TR199900211T2 (no)
WO (1) WO1998005313A1 (no)
ZA (1) ZA976791B (no)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL150907A (en) * 2002-07-25 2007-07-04 Stephan Cherkez Process for the preparation of stable amorphous calcium pseudomonate
US20050058673A1 (en) * 2003-09-09 2005-03-17 3M Innovative Properties Company Antimicrobial compositions and methods
WO2005049049A1 (en) * 2003-11-17 2005-06-02 Braintree Laboratories, Inc. Therapeutic peg solution concentrate
US20060051384A1 (en) 2004-09-07 2006-03-09 3M Innovative Properties Company Antiseptic compositions and methods of use
US8198326B2 (en) * 2004-09-07 2012-06-12 3M Innovative Properties Company Phenolic antiseptic compositions and methods of use
US9028852B2 (en) * 2004-09-07 2015-05-12 3M Innovative Properties Company Cationic antiseptic compositions and methods of use
TW200719884A (en) * 2005-03-10 2007-06-01 3M Innovative Properties Co Methods of treating ear infections
WO2006099359A2 (en) * 2005-03-10 2006-09-21 3M Innovative Properties Company Methods of reducing microbial contamination
MX2007010908A (es) * 2005-03-10 2007-12-05 3M Innovative Properties Co Composiciones antimicrobianas que comprenden esteres de acidos hidroxicarboxilicos.
AU2007317622B2 (en) 2006-10-27 2010-12-16 3M Innovative Properties Company Antimicrobial compositions
US20110097372A1 (en) * 2009-10-26 2011-04-28 Rucinski Paul J Devices, methods, and compositions for controlling infections
SE533425C2 (sv) * 2008-07-07 2010-09-21 Ambria Dermatology Ab Antimikrobiell sammansättning
WO2011056486A2 (en) * 2009-10-26 2011-05-12 Innovation Technologies, Inc. Devices, methods, and composition for controlling infections
DE102012215511A1 (de) 2012-08-31 2014-06-12 Schülke & Mayr GmbH Verfahren zur Herstellung einer Bispyridiniumalkan enthaltenden halbfesten Zubereitung
WO2017095352A1 (en) 2015-12-01 2017-06-08 Ataturk Universitesi Bilimsel Arastirma Projeleri Birimi Use of wax, olive oil, butter mixture and/ or its combination with varying ratios of boron and/ or derivatives thereof, in treatment of wounds, burns, and skin diseases
US10610499B2 (en) * 2016-05-06 2020-04-07 SaCSh Corp. Ophthalmic compositions

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3758686A (en) 1971-12-07 1973-09-11 American Cyanamid Co Method of using steroid acetonides
US4122158A (en) 1976-09-23 1978-10-24 Alza Corporation Topical therapeutic preparations
CA1196284A (en) 1982-05-28 1985-11-05 Joshua Oduro-Yeboah Pharmaceutical formulations
DE3375266D1 (en) 1983-06-08 1988-02-11 Ibm Deutschland Method and circuit arrangement for the generation of pulses of arbitrary time relation within directly successive pulse intervals with very high precision and temporal resolution
GB8415579D0 (en) 1984-06-19 1984-07-25 Beecham Group Plc Compounds
IT1202193B (it) 1985-10-31 1989-02-02 Pico Glass Spa Cornice porta-immagine
GB8530796D0 (en) 1985-12-13 1986-01-22 Beecham Group Plc Pharmaceutical composition
IE59628B1 (en) 1986-06-26 1994-03-09 Beecham Group Plc Treatment of fungal infections
US4847068A (en) 1987-08-06 1989-07-11 Johnson & Johnson Consumer Products, Inc. Skin care compositions
GB9507825D0 (en) * 1995-04-18 1995-05-31 Wet Pieter M De Method of treatment

Also Published As

Publication number Publication date
DE69707691T2 (de) 2002-08-01
IL128317A0 (en) 2000-01-31
AU708688B2 (en) 1999-08-12
DE69707691D1 (de) 2001-11-29
GB9616208D0 (en) 1996-09-11
US6214866B1 (en) 2001-04-10
EP0921791A1 (en) 1999-06-16
AU3771797A (en) 1998-02-25
CZ29199A3 (cs) 1999-07-14
PL331423A1 (en) 1999-07-19
JP2000517294A (ja) 2000-12-26
BR9710899A (pt) 2000-01-11
TR199900211T2 (xx) 1999-03-22
AR008797A1 (es) 2000-02-23
ATE207350T1 (de) 2001-11-15
ZA976791B (en) 1999-02-09
EP0921791B1 (en) 2001-10-24
CN1231606A (zh) 1999-10-13
CA2262430A1 (en) 1998-02-12
IL128317A (en) 2001-08-08
NO990440D0 (no) 1999-01-29
WO1998005313A1 (en) 1998-02-12
ES2163186T3 (es) 2002-01-16
KR20000029678A (ko) 2000-05-25
NZ333896A (en) 2000-06-23

Similar Documents

Publication Publication Date Title
NO982311L (no) Sammensetninger og fremgangsmÕter for forhindring og behandling av oral muscositt
EE200300212A (et) Ravimite kombinatsioonid (näiteks kloorpromasiin ja pentamidiin) neoplastiliste haiguste raviks
CL2004001174A1 (es) Composicion farmaceutica que comprende: 1-(4-fluorofenil)-3(r)-[3-(4-fluorofenil)-3(s)-hidroxipropil]-4(s)-(4-hidroxifenil)-2-acetidinona (ezetimiba) y excipientes; y su uso en el tratamiento y/o prevencion de aterosclerosis, hipercolesterolemia, dia
ZA200300712B (en) Pharmaceutical compositions for the treatment of mucositis, stomatitis and Behcet's syndrome.
AU6339599A (en) Quinoline derivatives and their use as antibacterial agents
EE201000018A (et) Ravimkompositsioonid, mis p?hinevad antikolinergiliselt toimivatel henditel ja
NO970210L (no) Heteroatomholdige cyklopentanopyridyl-oksazolidinoner
BR9710372B1 (pt) composto, e, composiÇço farmacÊutica.
CO4290346A1 (es) Formas de dosificacion de liberacion controlada de azitromicina
GB9917406D0 (en) Compounds
TR200100054T2 (tr) Paroksetin metansülfonat
AU5181200A (en) Pharmaceutical formulations for treating postmenopausal and perimenopausal women, and their use
ATE231872T1 (de) Thiazolopyrimidinderivate
DK1153610T3 (da) Matrixproteinpræparater til inflammatoriske og infektiøse tilstande
PT1228028E (pt) Sais de hidroxieicosatetraeniato, composicoes e metodos para utilizacao no tratamento de perturbacoes da secura ocular
PT1216256E (pt) Antibioticos macrolidos e tratamento de pasteurelose
SE9604348D0 (sv) Användning av hydroxyguanidiner
AU2000255628A1 (en) Formulation comprising thymol useful in the treatment of drug resistant bacterial infections
AU2005099A (en) Methods and compositions for the treatment and prevention of (staphylococcus aureus) infections
EE200300064A (et) Farmatseutiline kompositsioon C. pneumoniae pooltpõhjustatud infektsioonide raviks ja/või ennetamiseks, mahekompositsioon ja nende kasutamine
IT1305313B1 (it) 3,4 - diidro- 6- benzil-4-oxopirimidine sostituite e relativo processodi produzione e impiego nella terapia delle infezioni da hiv-1.
DE59813162D1 (de) Pharmazeutische zusammensetzung enthaltend clindamycin und clotrimazol, zur behandlung vaginaler infektionen
TR199900211T2 (xx) Mupirosin ve klorheksidin'den olu�an bile�im.
WO2001040473A3 (en) Pseudomonas aeruginosa antigens
YU39598A (sh) Upotreba duloksetina i njegova farmaceutska smeša

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application